Tuberculosis among adults starting antiretroviral therapy in South Africa: The need for routine case finding

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 9, 2012, Pages 1252-1259

  Hanifa, Yasmeen ^a   Fielding, K L ^b   Charalambous, S ^a   Variava, E ^c,d   Luke, B ^c,d   Churchyard, G J ^a,b,e   Grant, A D ^b  

^a AURUM INSTITUTE   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Tshepong Hospital Health Services   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Diagnosis; HIV infection; Screening; South Africa; Tuberculosis

Indexed keywords

ADULT; ANOREXIA; ANTIVIRAL THERAPY; ARTICLE; COUGHING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT SWEAT; POINT OF CARE TESTING; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; OUTPATIENT CLINICS, HOSPITAL; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; PUBLIC SECTOR; RADIOGRAPHY, THORACIC; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84865222085     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0733     Document Type: Article

References (35)

1. Lucas S B, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993; 7: 1569-1579. (Pubitemid 24008849)
2. Etard J F, Ndiaye I, Thierry-Mieg M, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006; 20: 1181-1189. (Pubitemid 43786107)
3. Koenig S P, Riviere C, Leger P, et al. High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis 2009; 48: 829-831.
4. Lawn S D, Myer L, Orrell C, Bekker L G, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005; 19: 2141-2148. (Pubitemid 41669003)
5. Johnson J L, Vjecha M J, Okwera A, et al.; the Makerere University-Case Western Reserve University Research Collaboration. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Int J Tuberc Lung Dis 1998; 2: 397-404. (Pubitemid 28239862)
6. Samb B, Sow P S, Kony S, et al. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis 1999; 3: 330-336. (Pubitemid 29166828)
7. Perlman D C, el-Sadr W M, Nelson E T, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis 1997; 25: 242-246. (Pubitemid 27364721)
8. World Health Organization. WHO Three I's meeting. Intensified case finding (ICF), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV. Report of a joint World Health Organization HIV/AIDS and TB Department meeting, 2-4 April 2008, Geneva, Switzerland: WHO, 2008. http://www.who.int/hiv/pub/meetingreports/WHO-3Is-meeting-report.pdf Accessed May 2012.
9. World Health Organization. Global tuberculosis control. WHO report 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2011. http://www.who.int/tb/ publications/global-report/2011/gtbr11-full.pdf Accessed May 2012.
10. Lawn S D, Myer L, Bekker L G, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20: 1605-1612. (Pubitemid 44162402)
11. Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007; 21: 713-719. (Pubitemid 46568628)
12. Lawn S D, Kranzer K, Edwards D J, McNally M, Bekker L G, Wood R. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS 2010; 24: 1323-1328.
13. National Department of Health South Africa. National antiretroviral treatment guidelines. Pretoria, South Africa: Department of Health, 2004. http://www.hst.org.za/uploads/files/sa-ART-Guidelines1.pdf Accessed May 2012.
14. Den Boon S, Bateman E D, Enarson D A, et al. Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis 2005; 9: 1088-1096. (Pubitemid 41433798)
15. Lawn S D, Brooks S V, Kranzer K, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011; 8: e1001067.
16. Bassett I V, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010; 51: 823-829.
17. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241500708-eng.pdf Accessed May 2012.
18. Fairall L R, Bachmann M O, Louwagie G M, et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med 2008; 168: 86-93.
19. Shah S, Demissie M, Lambert L, et al. Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 2009; 50: 537-545.
20. Were W, Moore D, Ekwaru P, et al. A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. Int J Tuberc Lung Dis 2009; 13: 47-53.
21. Shah M, Martinson N A, Chaisson R E, Martin D J, Variava E, Dorman S E. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol 2010; 48: 2972-2974.
22. Tamhane A, Chheng P, Dobbs T, Mak S, Sar B, Kimerling M E. Predictors of smear-negative pulmonary tuberculosis in HIV-infected patients, Battambang, Cambodia. Int J Tuberc Lung Dis 2009; 13: 347-354.
23. Day J H, Charalambous S, Fielding K L, Hayes R J, Churchyard G J, Grant A D. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 2006; 10: 523-529. (Pubitemid 43667640)
24. Lawn S, Edwards D J, Kranzer K, Vogta M, Bekker L G, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009; 23: 1875-1880.
25. Matee M, Mtei L, Lounasvaara T, et al. Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania. BMC Public Health 2008; 8: 68.
26. Getahun H, Kittikraisak W, Heilig C M, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011; 8: e1000391.
27. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
28. Foundation for Innovative New Diagnostics. FIND-negotiated prices for Xpert MTB/RIF and country list. Geneva, Switzerland: FIND, 2010. http://www.finddiagnostics.org/about/what-we-do/successes/find-negotiated- prices/xpert-mtb-rif.html Accessed May 2012.
29. Mosimaneotsile B, Talbot E A, Moeti T L, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003; 362: 1551-1552. (Pubitemid 37410196)
30. Shah N S, Anh M H, Thuy T T, et al. Population-based chest X-ray screening for pulmonary tuberculosis in people living with HIV/AIDS, An Giang, Vietnam. Int J Tuberc Lung Dis 2008; 12: 404- 410.
31. Johannessen A, Naman E, Ngowi B J, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008; 8: 52.
32. Stringer J S, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296: 782-793. (Pubitemid 44223102)
33. Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 2008; 22: 873-882. (Pubitemid 351563837)
34. Zachariah R, Fitzgerald M, Massaquoi M, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006; 20: 2355-2360. (Pubitemid 44789538)
35. Lawn S D, Wood R, Wilkinson R J. Changing concepts of 'latent tuberculosis infection' in patients living with HIV infection. Clin Dev Immunol 2011. pii: 980594.